COVID-19 Updates
From the Journals
Finerenone: ‘Striking’ cut in pneumonia, COVID-19 risks
Secondary analyses of the finerenone pivotal trials showed that the agent was linked with less infective pneumonia and blunted COVID-19 severity...
Feature
Is it flu, RSV, or COVID? Experts fear the ‘tripledemic’
Predicting exactly when cases will peak is difficult.
From the Journals
Myocarditis after COVID vax rare and mild in teens
Myocarditis in adolescents after Pfizer mRNA vaccination is rare with a mild and benign course and a favorable long-term prognosis, new data...
Feature
More data suggest preexisting statin use improves COVID outcomes
The researchers saw lower mortality and clinical severity among statin users.
Latest News
New COVID variant gaining traction in U.S.
Concerning features of the BQ.1 variant include mutations that could potentially escape vaccines and treatments for COVID-19.
Feature
You and the skeptical patient: Who’s the doctor here?
“I spoke to him on many occasions about the dangers of COVID, but he just didn’t believe me.”
Latest News
Most pediatric myocarditis caused by viruses
Vaccine-associated myocarditis remains clinically mild, compared with viral myocarditis, and far less likely than cardiac involvement from a COVID...
From the Journals
New deep dive into Paxlovid interactions with CVD meds
The review tackles potential drug-drug interactions with the antiviral drug and today’s most commonly prescribed cardiovascular drugs.
Opinion
The marked contrast in pandemic outcomes between Japan and the United States
Over time Japan has the least cumulative deaths per capita of any major country in the world.
Feature
For many, long COVID’s impacts go on and on, major study says
“This infection has become so common in a community because it’s so mild and spreading so rapidly that we’re seeing more long COVID symptoms than...
From the Journals
63% of long COVID patients are women, study says
The global study also found that about 6% of people with symptomatic infections had long COVID in 2020 and 2021.